No. CBD itself is not intoxicating — it does not produce the “high” associated with cannabis. But that answer applies only to pure CBD, and most labels don't guarantee pure CBD. The more useful question is the one underneath it: can a product labeled “CBD” legally contain THC? The answer is yes, and how much changes what “nonintoxicating” actually promises.
Can a Product Labeled CBD Contain THC?
Yes. Under the 2018 Farm Bill, hemp — and hemp-derived CBD by extension — is legally defined as cannabis with no more than 0.3 percent delta-9-THC by dry weight. That is not a zero-THC standard. It is a ceiling. A product can be fully compliant with federal hemp law, carry a “CBD” label, and still contain measurable THC.
How much THC ends up in a given bottle depends on how the product is made:
- Full-spectrum CBD is formulated to keep the hemp plant's other compounds intact, including THC up to that 0.3 percent legal limit. This is the category with the clearest built-in THC exposure.
- Broad-spectrum CBD is processed to remove THC after extraction. Removal is a manufacturing step, not a guarantee — it can be incomplete, and it varies between manufacturers and even between batches from the same manufacturer.
- CBD isolate is intended to contain no other cannabinoids, including THC. By design, this is the lowest-exposure category.
The word “nonintoxicating” on a label describes the compound's own pharmacology, not the bottle's full contents. A product can be accurately described as containing a nonintoxicating cannabinoid while still containing a federally permitted amount of an intoxicating one.
Does Nonintoxicating Mean No Impairment or Interactions?
No. “Nonintoxicating” is a statement about CBD's own mechanism — unlike THC, it doesn't produce euphoria on its own. It doesn't describe the product as a whole, and it isn't a safety claim. Two separate issues sit underneath it.
The THC that's actually present. If a full-spectrum product's THC content is high enough, or used frequently enough, the THC itself — not the CBD — can still contribute to impairment or show up on a standard drug screen. A nonintoxicating label doesn't change what a legally permitted trace of an intoxicating compound does with repeated exposure.
What the product has and hasn't been evaluated for. The FDA has stated that, apart from its one approved CBD drug product (Epidiolex), no CBD product on the market has gone through the agency's drug-approval review. Its own guidance is specific about what that means in practice: products that haven't been through that review “have not been evaluated as to whether they work, what the proper dosage may be if they do work, how they could interact with other drugs, or whether they have dangerous side effects or other safety concerns.” That gap — not the CBD label's wording — is why “nonintoxicating” can't tell you whether a product interacts with a blood thinner, an antidepressant, or anything else you're taking.
So the distinction holds: nonintoxicating is not the same as inactive, and it is not the same as risk-free. It describes one compound's behavior, not everything in the bottle, and not how that bottle behaves alongside anything else going on in your body.
Evidence Worksheet: Working Through a “Does CBD Get You High” Claim
Use this when you're reading a specific product's label or marketing copy and trying to separate what's established from what's asserted:
- Observed context: Where is the claim made — product label, sales page, a third-party review? Regulatory labeling and marketing copy are held to different standards, and only one is checked before it's printed.
- Source type: Is “nonintoxicating” sourced to the product's own certificate of analysis, to federal hemp law, or stated without any reference at all? A bottle's actual THC content is a lab result, not a label-writing choice.
- Evidence limit: Does the source speak to this specific product, or to CBD as a general category? A finding about isolate-grade CBD doesn't tell you what's in a full-spectrum gummy from a different manufacturer.
- Unresolved question: What hasn't been tested — drug interactions, long-term use, this batch's actual THC level? Naming the gap is more useful than reading past it.
- Next-step prompt: What would actually resolve the open question — a third-party certificate of analysis, a conversation with a pharmacist, a different test method? Not every gap closes with more reading; some require a qualified person.
Before You Compare Products
If the real question is whether a specific product could show up on a drug test, that's narrower and more answerable than “does CBD get you high,” and our clinical reading of CBD and drug testing walks through what the research shows, including how full-spectrum, broad-spectrum, and isolate products differ in practice.
Use the worksheet above on any label you're evaluating, and if you take medication or have a health condition, ask a pharmacist before adding a CBD product — not because the label is necessarily wrong, but because “nonintoxicating” was never the question that needed answering.
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.